JOHN J NANFRO

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology MARIANNA, FL NPI 1487749487

General Payments — all program years on this page

$327.82

  • Category: General Payments
  • Program years: PY2018
  • Record count: 21
  • As of (CMS publication): 2026-01-23

Latest program year (PY2018): $327.82 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2018) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $327.8221

By paying entity

Latest program year (PY2018) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $327.8221

Records — PY2018 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
549093283 Janssen Biotech, Inc. $15.57 01/11/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
559387375 Lilly USA, LLC $15.73 02/01/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
559387377 Lilly USA, LLC $12.12 03/06/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
559387379 Lilly USA, LLC $11.67 04/04/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
559992929 AstraZeneca Pharmaceuticals LP $15.35 02/07/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
560215857 AstraZeneca Pharmaceuticals LP $11.33 02/19/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
567482255 Amgen Inc. $21.89 01/25/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
567482259 Amgen Inc. $19.41 03/14/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
572149511 E.R. Squibb & Sons, L.L.C. $13.15 03/07/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
572149513 E.R. Squibb & Sons, L.L.C. $12.96 05/08/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
572149515 E.R. Squibb & Sons, L.L.C. $19.78 01/17/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
602079433 Genentech USA, Inc. $15.78 01/09/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
602295747 Genentech USA, Inc. $13.77 05/15/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
604205397 Merck Sharp & Dohme Corporation $18.69 01/23/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
608545521 Novartis Pharmaceuticals Corporation $12.86 03/15/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
608545523 Novartis Pharmaceuticals Corporation $19.29 01/30/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
608545525 Novartis Pharmaceuticals Corporation $13.62 05/09/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
608545527 Novartis Pharmaceuticals Corporation $11.18 02/21/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
610289619 PFIZER INC. $17.79 02/28/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
612861847 Puma Biotechnology, Inc. $16.95 03/12/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
614073343 Teva Pharmaceuticals USA, Inc. $18.93 01/18/2018 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.